JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5401
Escalade
ESCA
$269M
| $170K | ﹤0.01% |
12,632
-1,221
| -9% | -$15.2K |
2017 Q4
32 quarters
|
|
5402
VTEX
VTEX
$603M
| $169K | ﹤0.01% |
45,014
+16,381
| +57% | +$67.2K |
2023 Q2
10 quarters
|
|
5403
Superior Group of Companies
SGC
$207M
| $169K | ﹤0.01% |
17,449
-3,473
| -17% | -$33.9K |
2017 Q4
32 quarters
|
|
5404
Civista Bancshares
CIVB
$559M
| $169K | ﹤0.01% |
7,599
-73
| -1% | -$1.61K |
2016 Q4
36 quarters
|
|
5405
AllianzIM U.S. Equity Buffer10 Dec ETF
DECT
$126M
| $169K | ﹤0.01% |
4,599
-7,674
| -63% | -$276K |
2025 Q2
2 quarters
|
|
5406
Invesco BulletShares 2029 Municipal Bond ETF
BSMT
$287M
| $168K | ﹤0.01% |
7,271
-179
| -2% | -$4.14K |
2024 Q3
5 quarters
|
|
5407
CALL
BridgeBio Pharma
BBIO
$13B
| $168K | ﹤0.01% |
2,200
-10,900
| -83% | -$715K |
2024 Q4
4 quarters
|
|
|
TTAM
5408
Titan America SA
TTAM
$2.52B
| $168K | ﹤0.01% |
10,204
-32
| -0.3% | -$501 |
2025 Q2
2 quarters
|
|
5409
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$2.95B
| $168K | ﹤0.01% |
3,790
+2,626
| +226% | +$117K |
2021 Q1
19 quarters
|
|
5410
PUT
D-Wave Quantum Inc
QBTS
$6.38B
| $167K | ﹤0.01% |
+6,400
| New | +$186K |
2025 Q4
0 quarters
|
|
5411
Citizens
CIA
$178M
| $167K | ﹤0.01% |
34,551
-8,202
| -19% | -$45.2K |
2023 Q3
9 quarters
|
|
5412
AB Tax-Aware Long Municipal ETF
TAFL
$61.3M
| $167K | ﹤0.01% |
6,675
-8,580
| -56% | -$216K |
2024 Q1
7 quarters
|
|
|
STRS
5413
DELISTED
STRATUS PPTYS INC
STRS
| $164K | ﹤0.01% |
6,796
-1,669
| -20% | -$35K |
2016 Q4
36 quarters
|
|
5414
Sanara MedTech
SMTI
$320M
| $164K | ﹤0.01% |
7,007
-4,050
| -37% | -$105K |
2023 Q1
11 quarters
|
|
5415
Frontier Group Holdings
ULCC
$1.42B
| $163K | ﹤0.01% |
34,666
+283
| +0.8% | +$1.25K |
2021 Q2
18 quarters
|
|
5416
Standard BioTools
LAB
$290M
| $162K | ﹤0.01% |
126,686
+1,336
| +1% | +$1.79K |
2016 Q4
36 quarters
|
|
5417
Saratoga Investment
SAR
$267M
| $162K | ﹤0.01% |
7,021
-104
| -1% | -$2.36K |
2024 Q3
5 quarters
|
|
5418
Silvercrest Asset Management
SAMG
$81.7M
| $162K | ﹤0.01% |
10,662
-4,862
| -31% | -$70.6K |
2017 Q4
32 quarters
|
|
5419
Schwab International Dividend Equity ETF
SCHY
$2.5B
| $162K | ﹤0.01% |
5,429
+1,906
| +54% | +$55K |
2023 Q4
8 quarters
|
|
5420
Innovator Power Buffer Step-Up Strategy ETF
PSTP
$133M
| $162K | ﹤0.01% |
4,578
-3,102
| -40% | -$108K |
2023 Q3
9 quarters
|
|
|
TVACU
5421
Texas Ventures Acquisition III Corp Unit
TVACU
$214M
| $161K | ﹤0.01% |
15,000
| – | – |
2025 Q2
2 quarters
|
|
5422
PUT
Summit Therapeutics
SMMT
$13.4B
| $161K | ﹤0.01% |
9,200
| – | – |
2025 Q3
1 quarter
|
|
5423
Trinity Capital Inc
TRIN
$1.65B
| $161K | ﹤0.01% |
10,961
+5,000
| +84% | +$74.5K |
2025 Q2
2 quarters
|
|
|
DOO
5424
Bombardier Recreational Products
DOO
$3.88B
| $159K | ﹤0.01% |
2,252
+1,164
| +107% | +$79.3K |
2023 Q3
9 quarters
|
|
5425
John Marshall Bancorp
JMSB
$329M
| $159K | ﹤0.01% |
7,953
-3,595
| -31% | -$70.8K |
2022 Q2
14 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.